MGH Graduate Pharmacy Education Programs will be recruiting for the following residency programs for the 2025-2026 academic year:
1. PGY1/2 HSPAL:
The PGY-1/PGY-2 Health-System Pharmacy Administration and Leadership (HSPAL) Residency program is a 24-month program at Massachusetts General Hospital (MGH) with a combined Masters’ Degree in Pharmaceutical Sciences with a specialization in Health-System Pharmacy Administration from the University of North Carolina (UNC) Eshelman School of Pharmacy.
We currently offer one position for the combined PGY-1/PGY-2 Health-System Pharmacy Administration Residency and Leadership / MS Program.
If interested in applying, please message us through PPS to schedule a virtual interview!
If you have any additional questions prior to Midyear and PPS, feel free to contact our current residents or program director or coordinator.
2. PGY2 Internal Medicine:
This specialty residency offers trainees the opportunity to develop into Internal Medicine clinicians in a dynamic learning environment. The resident will work closely with primary services on the core internal medicine learning experiences – both with hospitalist teams as well as teaching teams made up of attending physicians, internal medicine residents and interns, and medical students from Harvard Medical School. Many elective rotations are available to the resident to gain knowledge and exposure to other specialty areas and further improve the care of internal medicine patients during future experiences. The resident will be involved in teaching pharmacy students and PGY1 residents throughout the residency year and will be able to serve as primary preceptor for a pharmacy student during the second half of the year. A formalized teaching certificate is available if the resident did not complete one during PGY1, as well as a research certificate, both optional experiences. The resident will also take part in administrative efforts related to internal medicine, including various medication safety initiatives and a position on one of our Pharmacy Department Collaborative Governance Committees.
We currently offer one position for the PGY2 IM Pharmacy Residency. Visit our website for more information: https://www.massgeneral.org/education/pharmacy-residency/pgy2-internal-medicine
If interested in applying, please message us through PPS to schedule a virtual interview!
If you have any additional questions prior to Midyear and PPS, feel free to contact our current residents or program director or coordinator.
We will be hosting Virtual Information Session prior to the ASHP Midyear Meeting – RSVP using the link below:
This dynamic specialty residency offers residents a range of learning experiences to develop critical skills in infectious diseases (ID) pharmacotherapy. The MGH ID division consists of 6 general adult ID consult teams (including a team staffed by experts in HIV care), an ID transplant consult service, a hematology/oncology ID consult service, and a pediatric ID consult service. Residents work collaboratively with pharmacy preceptors and infectious diseases fellows and faculty to deliver and ensure optimal treatments and outcomes. The resident will also play an active role in clinical and administrative antimicrobial stewardship initiatives across all hospital departments. Participation in the pharmacy department and ID division active learning opportunities (e.g. case conference, pharmacy grand rounds, and journal clubs) provides residents with tailored learning environments to excel and develop teaching and leadership skills. Teaching experience is provided through pharmacy and ID division group discussions, pharmacy students and residents’ preceptorship, and an optional teaching certificate program at Northeastern University School of Pharmacy (optional). Finally, residents contribute to local and system-wide interdisciplinary committees pertaining to infectious diseases management, antimicrobial stewardship, and antimicrobial usage. Visti our webpage for additional information: https://www.massgeneral.org/education/pharmacy-residency/pgy2-infectious-diseases
We will be hosting Virtual Information Session prior to the ASHP Midyear Meeting – RSVP using the link below
The Massachusetts General Hospital (MGH) PGY2 Solid Organ Transplant Pharmacy Residency Program provides an intellectually stimulating environment where the resident will care for transplant recipients while acquiring knowledge and skills that will prepare them to become a transplant pharmacotherapy specialist. The transplant pharmacy resident is viewed as an essential member of the multidisciplinary care team where they provide medication education and drug information to various health care professionals, patients and family members as part of their daily activities. Opportunities are available for precepting pharmacy students and PGY1 residents and leading lectures at the various colleges of pharmacy in the area. The addition of an optional teaching certificate program at Northeastern University School of Pharmacy allows the resident to refine their skills as a pharmacy educator who can progress into an academic role in the area of transplant pharmacotherapy. A flipped research model provides the transplant resident the opportunity to complete a research project that can be submitted for presentation at a national transplant meeting in addition to developing their own research idea during the second half of the year. Through this process the resident will learn foundational skills that can be applied as a clinical researcher in a transplant pharmacy practice setting. Finally, the resident will participate in numerous MGH Transplant Center committees and activities, where they will be exposed to the regulatory and accreditation standards by which a transplant program must abide.
The transplant program at Massachusetts General Hospital is the largest in New England. The transplant pharmacy resident will gain exposure to adult and pediatric transplantation and will care for heart, lung, liver, kidney, pancreas, islet and vascular composite allograft transplant recipients.
We will be hosting Virtual Information Session prior to the ASHP Midyear Meeting – RSVP using the link below
Massachusetts General Hospital (MGH) is a 1,045-bed, academic teaching hospital in Boston, MA. It is the largest hospital in New England, and the third oldest in the United States. Consistently ranked as one of the top hospitals in the nation by US News & World Report, Mass General’s history and achievements have earned it a reputation as one of the foremost medical centers in the world for centuries. The hospital's reputation dates as far back as 1846, when the first public demonstration of the use of ether as an anesthetic during surgery took place in the Mass General Ether Dome. MGH is affiliated with Harvard Medical School and conducts the largest hospital-based research program in the U.S. MGH is part of Mass General Brigham which is the health system established by Mass General and Brigham and Women’s Health in the late 1990’s. Currently, Mass General Brigham is made up of 12 hospitals located in Massachusetts and New Hampshire.
Department of Pharmacy: Established in 1845, the Mass General Department of Pharmacy provides innovative and comprehensive direct patient care and operational services to the inpatient hospital and numerous outpatient clinics. The Department of Ph...armacy encompasses a staff of approximately 350 full-time employees, a $450 million annual drug budget, and 15 locations, including the Main Inpatient Pharmacy, Operating Room Pharmacy, Wang Outpatient Pharmacy, Yawkey Ambulatory Oncology Infusion Pharmacy, General and Oncology Clinical Trials Pharmacy, as well as numerous outpatient and ambulatory oncology pharmacies off-campus. Over 9 million medication doses are dispensed annually and are supported by medication carousels, anesthesia workstations, and automated dispensing cabinets. The hospital has a fully implemented electronic medical record across the institution. Pharmacists are involved in complex medical management, integrated into multidisciplinary teams and provide services such as therapeutic drug monitoring, patient counseling, drug information, medication reconciliation and acute emergency response.